 Patent Application Title |
Patent App Num. |
Date |
| Formulations, their use as or for producing dishwashing detergents and their production | 20130102516 | 20130425 |
 (D) at least one compound selected from alkali metal percarbonate, alkali metal perborate and alkali metal persulfate.
... |
| Stable and non-precipitating aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid, and methods of their preparation and use | 20120214670 | 20120823 |
 The present invention generally relates to aqueous compositions containing salts of (S)-(+)-abscisic acid, the surfactant Atlox™ 4913, and the color stabilizers sodium citrate and sodium acetate, methods of their preparation, and methods of their agricultural use.
... |
| Conductive silver powder preparation method | 20120025152 | 20120202 |
 A conductive silver powder preparation method includes the following steps: forming a silver salt solution by mixing a silver salt with a DI (De-ionized) water; forming a sodium citrate solution by well-mixing a sodium citrate with the DI water; heating the silver salt solution until maintaining the silver salt solution at a constant temperature of no less than 80° C.; forming a brown solution by adding the sodium citrate solution into the heated silver salt solution; cooling the brown solution to the room temperature for precipitating to form a brown powder; and forming a conductive silver powder by freezing and drying the brown powder. This method simplifies the prior chemical method without usages of toxic reducing agent and additional protective agent, and complies with the requirements... |
| Process for producing fine silver particle colloidal dispersion, fine silver particle colloidal dispersion, and conductive silver film | 20110012068 | 20110120 |
| A process for producing a fine silver particle colloidal dispersion which can simply form conductive silver layers and antimicrobial coatings by screen printing or the like. The process is characterized by having a reaction step of allowing an aqueous silver nitrate solution to react with a mixed solution of an aqueous iron(II) sulfate solution and an aqueous sodium citrate solution to form an agglomerate of fine silver particles, a filtration step of filtering the resultant agglomerate of fine silver particles to obtain a cake of the agglomerate of fine silver particles, a dispersion step of adding pure water to the cake to obtain a first fine silver particle colloidal dispersion of a water system in which dispersion the fine silver particles have been dispersed in the... |
| Low fat processed cheese slice-on-slice and block | 20100330233 | 20101230 |
| Low fat (less than 5 percent, but preferably less than 3 percent) cheese slice-on-slice and block products. The product can be made with natural skim milk cheese; additional dairy solids; and have from about 53 to about 55 total weight percent of water; from about 2 to about 2.8 total weight percent of emulsifier salts of at least citrate, such as di-sodium citrate and optionally a phosphate, such as di-sodium phosphate. Citrate/phosphate ratios can be up to about 50/50. The product can have 20 to 30 total weight percent protein, of which from about 12 to 25 total percent weight is functional casein protein; and moisture/functional casein protein ratio from about 22 to 56 percent. Methods to manufacture can include blending and hydrating components before cooking... |
| |
| Automatic dishwashing detergent | 20100323941 | 20101223 |
| An automatic dishwashing detergent, comprising, by weight: 2-10% sodium citrate dehydrate; 0.5 to 2.0% citric acid; 0.5 to 10.0% of a first surfactant, 0.8 to 1.1% xanthan gum; 0.1 to 5.0% of an enzyme; 0.5 to 10.0% of a second surfactant; and the balance being water. The dishwashing detergent can optionally include a preservative and/or an essential oil.
... |
| Composition and method for stimulation of oil production in sandstone formations | 20100288499 | 20101118 |
| A method and a composition for stimulating oil production from wells which have ceased production by pumping in a mixture of gluconic, oxalic and citric acids, isopropanol, ethylene glycol and sodium citrate between pre-flush and over-flush intervals, which composition and method does not include the use of hydrochloric acid or hydrofluoric acid.
... |
| Flavoring systems for pharmaceutical compositions and methods of making such compositions | 20100280055 | 20101104 |
| A flavoring system for a liquid pharmaceutical composition and pharmaceutical compositions containing such flavoring systems are disclosed. Flavoring systems of the invention include at least one sweetening agent, at least two flavored ingredients, and at least one flavor modifier selected from the group consisting of citric acid, sodium citrate, sodium chloride, and mixtures thereof. At least two of the flavored ingredients are selected from the group consisting of a vanilla flavored ingredient, a peppermint flavored ingredient, a menthol flavored ingredient, a cotton candy flavored ingredient, and mixtures thereof. The one or more sweetening agents comprise glycerin, monoammonium glycyrrhizinate, saccharin sodium, acesulfame potassium, high fructose corn syrup, and/or mixtures thereof. Pharmaceutical compositions of the invention include a flavoring system of the invention, a solvent system, and at... |
| Glycine stabilized lyophilized plasma | 20100273141 | 20101028 |
| The invention is directed to stabilized whole-cell plasma, which retains the integrity and overall stability of the proteins and other macromolecules of the plasma. Stabilization is accomplished by the addition of glycine to plasma which allows for stabilization prior to freeze drying. Glycine, in the presence of the salt concentration in the plasma, does not recrystallize and acts as a superior stabilizer for the lyophilized plasma. The stability of the freeze dried plasma may be further improved by addition of protectants including calcium chloride, trisodium citrate, hydroxyethyl starch, ammonium sulfate and citric acid to maintain physiologic pH. Superior stability for a wide variety of plasma proteins and functions is shown. A system for the large scale preparation of sterile lyophilized plasma is also provided.
... |
| Citrulline-containing beverage | 20100255174 | 20101007 |
| The invention provides an easy-to-drink beverage that contains citrulline, wherein the generation of bad odors due to storage or heating is suppressed. In particular, the invention provides a beverage that contains citrulline and citric acid, as well as sodium citrate or disodium hydrogen phosphate.
... |
| Insulin formulations for rapid uptake | 20100227795 | 20100909 |
| Injectable insulin formulations with improved stability and rapid onset of action are described herein. The formulations may be for subcutaneous, intradermal or intramuscular administration. In the preferred embodiment, the formulations are administered via subcutaneous injection. The formulations contain insulin in combination with a chelator and dissolution agent, and optionally additional excipients. In the preferred embodiment, the formulation contains human insulin, a zinc chelator such as EDTA and a dissolution agent such as citric acid or sodium citrate. These formulations are rapidly absorbed into the blood stream when administered by subcutaneous injection. In the preferred embodiment, the insulin is provided as a clear liquid, neutral pH, in a multi-use sterile vial. In an alternative embodiment, the insulin is provided as a powder in a sterile vial. This... |
| Use of a chromatography substrate for reducing the amount of adamts13 in a solution derived from plasma | 20100193440 | 20100805 |
| An ion-exchange chromatography support for reducing the ADAMTS13 amount present in a plasma-derived solution containing human von Willebrand factor. The support includes a large-pore, vinyl polymer-type resin bearing DEAE groups, and a buffer including trisodium citrate, sodium chloride, calcium chloride, glycine and lysine.
... |
| Extraction of hemp fibers | 20100147472 | 20100617 |
| A method of extracting hemp fibers from decorticated hemp bast skin involves pre-treating the decorticated hemp bast skin with an aqueous solution containing di-sodium citrate, tri-sodium citrate or a mixture thereof having a pH of from about 6-13 at temperature of about 90° C. or less; and subsequently treating recovered fiber with a enzyme. Determining the extent of completion of a plant fiber degumming process involves treating degummed fiber with a recombinant pectinase expressed in an organism that produces neither cellulose nor xylanase, to release reducing sugar from any residua pectin on the degummed fiber, and, quantifying the released reducing sugar.
... |
| |
| Method for detecting human parvovirus antigen | 20100105069 | 20100429 |
| A method for detecting human parvovirus/erythrovirus antigen in a sample comprises contacting a buffer having a pH in the range 3.0 to 4.0, suitably a citrate/trisodium citrate buffer, with the sample followed by the measurement of the antigen. The measurement of the antigen can be by virus capture enzyme immunoassay. The method is a good indicator of recent infection and can be used in the screening of individual plasma units or pools from which blood products are extracted.
... |
| Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application | 20090309597 | 20091217 |
| The preparation of labelled cells proceeds by adding to the complete culture medium 5-20 μl, to advantage 10 μl, of a colloid containing 0.05-45 mg iron oxide per ml, to advantage 1-5 mg iron oxide per ml of the medium, and culturing the cells for a period of 1-7 days, to advantage for 1-3 days, at 37° C. and 5% of CO2.
... |
| Dialysis preparation | 20090294360 | 20091203 |
| The present invention provides a pharmaceutical composition for dialysis wherein the decline of ionized calcium concentration in an acetate-free bicarbonate dialysate comprising no acetic acid and/or sodium acetate is controlled. The present invention further provides a dialysis agent A that comprises electrolytes, citric acid and/or citrate as pH adjuster, and/or glucose, for preparation of bicarbonate dialysates; the agent A characterized by being adjusted by citric acid and/or citrate so as to keep the electrolyte ionized calcium concentration not less than 1 mmol/L in a prepared bicarbonate dialysate. In a specific aspect of the present invention, sodium citrate is used as citrate, and the present invention provides a dialysate obtained from above.
... |
| Fine silver particle colloidal dispersion, coating liquid for silver film formation, processes for producing these, and silver film | 20090256118 | 20091015 |
| A process for producing a fine silver particle colloidal dispersion the fine silver particles of which have a larger average particle diameter than those in the conventional Carey-Lea process and also which has superior dispersion stability. An aqueous silver nitrate solution is allowed to react with a mixed solution of an aqueous iron(II) sulfate solution and an aqueous sodium citrate solution, and the resultant reaction fluid containing an agglomerate of fine silver particles is left at 0 to 100° C. to obtain an agglomerate of fine silver particles having grown into granular particles. Next, this agglomerate of fine silver particles having grown into granular particles is filtered, and, to the resultant cake of the agglomerate of fine silver particles, pure water is added to obtain a... |
| Health-related liquid compositions | 20090215704 | 20090827 |
| There are disclosed liquid compositions comprising water, a fiber such as inulin, and a glycosaminoglycan that is selected from chondroitin sulfate, glucosamine, or a mixture thereof. The liquid compositions may further comprise at least one or more sweeteners, a source of calcium, at least one or more flavor additives, trehalose, at least one or more acids, sodium citrate, monopotassium phosphate, fruit juice, fruit juice concentrate, or the like, and any combination thereof. The liquid compositions may be suitable for use in health-related applications, among other applications.
... |
| Health-related liquid compositions | 20090215704 | 20090827 |
| There are disclosed liquid compositions comprising water, a fiber such as inulin, and a glycosaminoglycan that is selected from chondroitin sulfate, glucosamine, or a mixture thereof. The liquid compositions may further comprise at least one or more sweeteners, a source of calcium, at least one or more flavor additives, trehalose, at least one or more acids, sodium citrate, monopotassium phosphate, fruit juice, fruit juice concentrate, or the like, and any combination thereof. The liquid compositions may be suitable for use in health-related applications, among other applications.
... |
| Health-related liquid compositions | 20090215704 | 20090827 |
| There are disclosed liquid compositions comprising water, a fiber such as inulin, and a glycosaminoglycan that is selected from chondroitin sulfate, glucosamine, or a mixture thereof. The liquid compositions may further comprise at least one or more sweeteners, a source of calcium, at least one or more flavor additives, trehalose, at least one or more acids, sodium citrate, monopotassium phosphate, fruit juice, fruit juice concentrate, or the like, and any combination thereof. The liquid compositions may be suitable for use in health-related applications, among other applications.
... |
| Health-related liquid compositions | 20090215704 | 20090827 |
| There are disclosed liquid compositions comprising water, a fiber such as inulin, and a glycosaminoglycan that is selected from chondroitin sulfate, glucosamine, or a mixture thereof. The liquid compositions may further comprise at least one or more sweeteners, a source of calcium, at least one or more flavor additives, trehalose, at least one or more acids, sodium citrate, monopotassium phosphate, fruit juice, fruit juice concentrate, or the like, and any combination thereof. The liquid compositions may be suitable for use in health-related applications, among other applications.
... |
| Health-related liquid compositions | 20090215704 | 20090827 |
| There are disclosed liquid compositions comprising water, a fiber such as inulin, and a glycosaminoglycan that is selected from chondroitin sulfate, glucosamine, or a mixture thereof. The liquid compositions may further comprise at least one or more sweeteners, a source of calcium, at least one or more flavor additives, trehalose, at least one or more acids, sodium citrate, monopotassium phosphate, fruit juice, fruit juice concentrate, or the like, and any combination thereof. The liquid compositions may be suitable for use in health-related applications, among other applications.
... |
| Sheet substrates impregnated with aromatic releasing compositions and a method of delivery of aromatic releasing compositions | 20090191249 | 20090730 |
| An article of manufacture and a method directed to application of aromatic releasing compositions impregnated within substrates such as non-woven paper materials (e.g., wipes, paper towels) and dispensable cloth materials (e.g., gauze or a thin fabric of silk, linen, or cotton materials) for providing relief from cold, allergies, sinus and symptoms associated with respiratory disorders, the aromatic releasing compositions including the following: Menthol; Camphor; Eucalyptus oil; Cedarleaf Oil; Myristica Oil; Peppermint Oil; Lavender oil; Methyl Salicylate; Naproxen; Nutmeg Oil and Thymol; Beclometasone dipropionate; Benzethonium chloride with base solution consisting of Emollients, Emulsifiers and Moisturizer; Deionized Water; Vegetable Oil; Dicaprylyl Carbonate; Glyceryl Oleate; Polyglyceryl-2 Dipolyhydroxystearate; Cetearyl Isononanoate; Ceteareth-20; Cetearyl Alcohol; Glyceryl Stearate; Glycerin; Cetyl Palmitate; Ceteareth-12, Lauryl Glucose Carboxylate; Lauryl Glucoside; Sodium Citrate; Citric Acid; Benzethonium Chloride... |
| Method for reducing metal ion with nanosilicate platelets and dispersing metal nanoparticle and product thereof | 20090149592 | 20090611 |
| The present invention provides a method for reducing metal ions (for example, silver ions) and stably dispersing metal nanoparticles by nanosilicate platelets. An organic dispersant, nanosilicate platelets and a metal ionic solution are mixed to perform a reductive reaction, wherein the organic dispersant is tri-sodium citrate dihydrate (SCD), chitosan or polyvinyl pyrrolidone (PVP), to produce a mixture of stably dispersed metal nanoparticles.
... |
| Skin care products containing multiple enhancers | 20090117061 | 20090507 |
| The present invention provides a skin care product comprising at least two enhancers and at least one skin care ingredient, wherein the at least two enhancers are selected from cyclodextrin, pentasodium pentetate, phytic acid, potassium citrate, sodium citrate, potassium gluconate and sodium gluconate.
... |
| Removable coating and application method | 20090053497 | 20090226 |
| A removable, colored X-alginate coating composition for a surface includes an aqueous solution of sodium alginate including a colorant and an aqueous solution containing divalent cations. In various aspects, the aqueous solution containing divalent cations includes, but is not limited to, calcium chloride, calcium chlorate, calcium carbonate, magnesium chloride, magnesium chlorate, or magnesium carbonate. The applied coating composition is advantageously in the form of a thin film coating. The thin film may have a thickness about equal to or greater than 10 nanometers and may include more than a single layer; for example, two mono-layers, but not limited as such. Any one of the plurality of monolayers may have a thickness about equal to or greater than five nanometers. Advantageously, the X-alginate coating composition according to... |
| Mixture and beverage made therefrom for protecting cellular hydration | 20090017167 | 20090115 |
| A beverage or tablet or mixture for preparing a beverage, the beverage with rehydration characteristics having an osmolality between approximately 150 to approximately 350 mOsm/liter. Embodiments of the beverage include a weight:weight ratio of sodium and potassium. Embodiments of the beverage include one or more rapidly releasing sugar and one or more delayed releasing sugar. Some embodiments include trehalose, citric acid, tocopherols, sodium chloride, calcium lactate pentahydrate, sodium citrate, potassium chloride, potassium citrate, ascorbic acid, magnesium oxide, sucralose, beta carotene and/or folic acid.
... |
| Enhanced production of blood clotting factors and fibrin fabric | 20090018313 | 20090115 |
| The blood collection, processing and transfer by separation of discrete components containing additional citrate (at least about trisodium citrate 9% w/v) in one or other of collection or processing bag provides for enhanced yield and purity of cryoprecipitate. Inhibiting the activation or denaturation of blood components including blood cells and plasma proteins and with the removal of the activated and denatured components thereby improving safety and efficacy of end products. The inventive process is particularly suited to an improved extraction process to yield concentrated clotting factors from single donors or limited pools without use of chromatography. Following extraction the remaining cryoprecipitate can advantageously be formed into a fibrin fabric used in surgeries and in the treatment of wounds.
... |
| Sampling system and method | 20090004688 | 20090101 |
| A sampling system and method may use a kit that has a package enclosing a swab and a receptacle. The swab may have a shaft and a tip. The tip may be substantially made of calcium alginate. The receptacle may contain a diluent, such as sodium citrate, and glass beads. The swab may be used in an environment to sample microorganisms present on surfaces or in equipment. The kit may be used in a method of sampling and the resulting sample may be used in a method of quantitative testing.
... |
| Contact lens package solution | 20080307751 | 20081218 |
| An aqueous contact lens storage solution comprises a viscoelastic rheology modifier; and not more than 0.3% w/v of an alkali metal salt; the solution has a pH of between 6.0 and 8.0 and an osmolality of between 100 and 400 mOsm/kg, and the solution has viscoelastic properties, even if heat sterilized at 121° C. for at least 15 minutes. The viscoelastic rheology modifier may be selected from the following acids or their alkali metal salts: hyaluronic acid, poly (acrylic acid), crosslinked poly (acrylic acid), poly (methacrylic acid), carboxymethyl cellulose, alginic acid and mixtures thereof. The alkali metal salt may be present in an amount of from 0.01% to 0.3% w/v, and be selected from sodium chloride, sodium bicarbonate, sodium dihydrogen phosphate, disodium hydrogen phosphate, trisodium phosphate,... |
| Method for collecting a live placenta cord stem cell | 20080279956 | 20081113 |
| The present invention discloses a method for collecting a live placenta cord stem cell, in which the live placenta cord stem cells are required to be healthy and plenty of endocrine. The cord is first picked with a proper length, then dipped in the sodium citrate solution of a specific concentration as an anticoagulant and then preserved in a refrigerator to maintain natural activity thereof. The collected stem cells can be implanted into human bodies without synthetic chemicals, side effects and rejection, and therefore are suitable for treating many diseases.
... |
| Polyvinyl pyrollidone cryoprecipitate extraction of clotting factors | 20080281081 | 20081113 |
| Blood collection, processing and transfer leads to the separation of discrete fractions by adding additional citrate (trisodium citrate) to bring the citrate concentration to 10%-15% w/v thereby leading to enhanced yield and purity of cryoprecipitate. The improved cryoprecipitate then yields concentrated clotting factors by an improved extraction process which uses polyvinyl pyrollidone to reduce the extraction of fibrinogen. Following extraction the remaining cryoprecipitate can advantageously be formed into a fibrin fabric used in surgeries and in the treatment of wounds
... |
| Method for producing a copper layer on a substrate in a flat panel display manufacturing process | 20080248194 | 20081009 |
| Methods and apparatus for producing a copper layer on substrate in a flat panel display manufacturing process, where the copper is electrodelessly deposited on a substrate to form a copper interconnection layer. A copper solution containing: CuSO4 5H2O as a copper source, potassium sodium tartrate or trisodium citrate as a complexing agent, glyoxylate, glyoxilic acid or sodium phosphate as a reducing agent, a sulfur organic compound as a stabilizing agent, and a pH adjusting agent, is used to form the copper interconnection layer on the substrate.
... |
| Ultra-high yield intravenous immune globulin preparation | 20080242844 | 20081002 |
| An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs one or more salts from a group of salts comprising sodium citrate, sodium acetate, sodium gluconate, ammonium sulfate, sodium chloride, sodium sulfate and ammonium chloride in two initial fractionation steps, followed by diafiltration to remove those salts employed. A process which employs alcohol via the process of the disclosed inventive method is also disclosed.
... |
| Particles for inhalation having rapid release properties | 20080226730 | 20080918 |
| The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent or any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
... |
| Particles for inhalation having rapid release properties | 20080227690 | 20080918 |
| The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent or any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
... |
| Bone cement | 20080182920 | 20080731 |
| A bone cement comprises a zinc-based glass and polyalkenoate acid. In addition, the cement comprises a controlled amount of tri-sodium citrate (Na3C6H5O7) (“TSC”). The cement has enhanced rheology without negatively impacting on the mechanical properties. Controlled addition of TSC significantly improves the rheology of the bone cements, increasing working and setting times (illustrated in FIG. 1). For three formulations of the working time can be adjusted from less than 50 seconds to almost 120 seconds; concomitantly working times improve from 58 seconds to duration in excess of 300 s.
... |
| Oral/buccal transmucosal delivery methods for electrolyte compositions including xylitol | 20080152695 | 20080626 |
| The present disclosure is an oral/buccal transmucosal delivery method which includes, generally, an edible thin film strip including a predetermined volume of xylitol. The edible thin film strip of the present disclosure is preferably comprised of potassium chloride; trisodium citrate; sodium chloride; glucose, and; xylitol.
... |
| Sport drink containing amino acids and carbohydrates | 20070270355 | 20071122 |
| A composition includes a plurality of amino acids. The plurality of amino acids includes at least one essential amino acid and at least one non-essential amino acid. The plurality of amino acids also includes at least one branch-chain amino acid. The composition also includes a source of carbohydrates. The compositions also includes purified water. The plurality of amino acids comprises about 1 wt % of the composition. A composition includes a plurality of amino acids, sodium citrate, sodium chloride, potassium phosphate, flavoring, a source of carbohydrates, and purified water. In some embodiments of the composition, the plurality of amino acids includes alanine, arginine, aspartate, cystine, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonin, tryptophan, tyrosine, and valine.
... |
| Oral rehydration compositions | 20070259054 | 20071108 |
| An oral rehydration mixture (ORM) may include from 47 to 75 wt % of a glucose containing saccharide, from 6 to 13 wt % sodium chloride, from 6.5 to 19 wt % potassium chloride, from 2 to 5 wt % sodium citrate, from 10 to 16 wt % citric acid, and from 0.3 to 0.5 wt % of a chlorinated sucrose isomer. The ORM may be combined with water to provide an oral rehydration solution (ORS). A method of treating dehydration may include administering to a subject the ORS.
... |
| Method for forming zno nano-array and zno nanowall for uv laser on silicon substrate | 20070220713 | 20070927 |
| Provided are low-temperature formation methods of a perfectly oriented ZnO nanorod array and a new-type ZnO nanowall array having a new crystal growth rate, morphology, and orientation, from ZnO nanoparticles coated on a substrate. The method of forming the ZnO nanorod array includes synthesizing ZnO nanoparticles, coating on a substrate the ZnO nanoparticles serving both as a buffer layer and a seed layer, and growing the ZnO nanoparticles into crystals in a nutrient solution containing Zn nitrate, Zn acetate, or a derivative thereof, and hexamethylenetetramine. The method of forming the ZnO nanowall array includes synthesizing ZnO nanoparticles, coating on a substrate the ZnO nanoparticles serving both as a buffer layer and a seed layer, and growing the ZnO nanoparticles into crystals in a nutrient solution containing... |
| High load particles for inhalation having rapid release properties | 20070123449 | 20070531 |
| The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent or any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
... |
| Process for metabolic control and high solute clearance and solutions for use therein | 20070110829 | 20070517 |
| The present disclosure describes novel standardized citrate replacement fluid solutions and a standardized dialysate solution for use with CRRT methods. The standardized citrate replacement fluid solutions and standardized dialysate solutions do not require modification based on the clinical status of the individual patients. The use of the standardized solutions described herein offers significant advantages over the prior art solutions used in CRRT. The present disclosure describes superior metabolic and electrolyte control and significantly increased dialyzer patency in: (a) 24 intensive care unit (ICU) patients with ARF using a 0.67% trisodium citrate replacement fluid solution, and (b) 32 ICU patients with ARF using a 0.5% trisodium citrate replacement fluid solution. Both groups were treated with Bicarbonate-25 dialysate and achieved effluent rates of 35 mL/kg/hr.
... |
| Additive for meat product, meat product and method for making same | 20070110884 | 20070517 |
| A process of treating a slab of steak is disclosed. The process comprises cleaning the steak and then placing the steak in a tenderiser to tenderise the steak. The process then includes pumping a meat additive into the slab of steak. The meat additive comprises sodium alginate; at least one of sodium lactate, sodium citrate and citric acid; and water and optionally also slats and vegetable protein. Thereafter the slab of steak is placed into a vacuum massager and massaged for a period of time. An amount of hydrolysed calcium sulphate and/or carrageenan is added to the slab of steak before or after said vacuum massaging step. The next step involves forcing the meat through an orifice and into a meat casing having at least one... |
| Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process | 20070099260 | 20070503 |
| Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved.
... |
| Water-soluble aspirin composition | 20070092561 | 20070426 |
| Compositions in which aspirin is present in combination with alkaline compounds, especially those containing water of crystallization (hydrates), deteriorate on standing. This deterioration may take several forms: It can be a physical deterioration in which such aspirin compositions become completely unmanageable, wet, gummy, sticky masses; or chemical decomposition in which aspirin loses its molecular structure chiefly by losing the acetyl group. The latter is accompanied by formation of acetic acid, the mixture developing its characteristic acetic odor. In both cases, such compositions become entirely unsuitable for all practical commercial and medicinal purposes. Yet, when preparation of water-soluble aspirin compositions is desired, it is impossible to avoid the use of alkaline compounds. This is because the only known method of converting aspirin into soluble form is by... |
| Nickel plating solution and its preparation method, nickel plating method and printed wiring board copper foil | 20070071999 | 20070329 |
| A nickel plating solution preparation method has the steps of: dissolving in water 100 g/L or more and less than 200 g/L of nickel sulfate, and 10 g/L or more and less than 30 g/L of sodium citrate or 8 g/L or more and less than 25 g/L of citric acid, but adding no nickel chloride; and adjusting a pH of the resultant solution to 2 or more and less than 4. Another nickel plating solution preparation method has the steps of: dissolving in water 100 g/L or more and less than 200 g/L of nickel sulfate, and 10 g/L or more and less than 30 g/L of sodium citrate or 8 g/L or more and less than 25 g/L of citric acid, but adding no... |
| Ultra-high yield intravenous immune globulin preparation | 20070049732 | 20070301 |
| An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs sodium citrate in two initial fractionation steps, followed by diafiltration to remove sodium citrate.
... |
| Ultra-high yield intravenous immune globulin preparation | 20070049733 | 20070301 |
| An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs sodium citrate in two initial fractionation steps, followed by diafiltration to remove sodium citrate.
... |
| Ultra-high yield intravenous immune globulin preparation | 20070049734 | 20070301 |
| An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs one or more salts from a group of salts comprising sodium citrate, sodium acetate, sodium gluconate, ammonium sulfate, sodium chloride, sodium sulfate and ammonium chloride in two initial fractionation steps, followed by diafiltration to remove those salts employed. A process which employs alcohol via the process of the disclosed inventive method is also disclosed.
... |
| Compositions and methods for preserving cut apples | 20070042093 | 20070222 |
| This invention is a novel composition for preserving fresh cut apples comprising a mixture of ascorbic acid, and one or more of calcium chloride, calcium carbonate, magnesium chloride, calcium hydroxide, and optionally, citric acid or sodium citrate. This invention also relates to a method of preserving fresh cut apples by treating the cut apples with the novel composition dissolved in water and packaging the treated fresh cut apples in a modified atmosphere package.
... |
| Collection systems for cytometer sorting of sperm | 20070026379 | 20070201 |
| Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved.
... |
| Furan polymer impregnated wood | 20060292366 | 20061228 |
| A furan polymer impregnated wood which comprises wood impregnated with a polymerizable furfuryl alcohol monomer mixture containing at least water and furfuryl alcohol, and an initiator selected from the group consisting of anhydrides, acids and combinations thereof is described. For longer storage life, the mixture contains a stabilizer selected from sodium carbonate, sodium bicarbonate, sodium citrate, phosphates and water-soluble lignin derivatives such as calcium and ammonium salts of lignosulfonic acids, and combinations thereof. A method for preparing a furan impregnated wood and uses thereof is also described.
... |
| Method for preparing liquid colloidal dispersion of silver particles, liquid colloidal dispersion of silver particles, and silver conductive film | 20060264518 | 20061123 |
| A process for producing a fine silver particle colloidal dispersion which can simply form conductive silver layers and antimicrobial coatings by screen printing or the like. The process is characterized by having a reaction step of allowing an aqueous silver nitrate solution to react with a mixed solution of an aqueous iron(II) sulfate solution and an aqueous sodium citrate solution to form an agglomerate of fine silver particles, a filtration step of filtering the resultant agglomerate of fine silver particles to obtain a cake of the agglomerate of fine silver particles, a dispersion step of adding pure water to the cake to obtain a first fine silver particle colloidal dispersion of a water system in which dispersion the fine silver particles have been dispersed in the... |
| Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment | 20060247426 | 20061102 |
| The invention relates to a method for obtaining cryoprecipitatable proteins, comprising a viral inactivation step by thermally treating a lyophilisate of these proteins, comprising, before rendering the proteins in the form of a lyophilisate, an initial addition step, to these proteins, of a stabilizing and solubilizing formulation containing a mixture consisting of arginine, at least one hydrophobic amino acid and of tribasic sodium citrate. The invention also relates to a concentrate consisting of at least one cryoprecipitable protein containing the stabilizing and solubilizing formulation introduced according to the method and being suited for therapeutic use.
... |
| Composite nanoparticle and process for producing the same | 20060234417 | 20061019 |
| There is provided composite nano-particles comprising nano-crystal particles dispersed stably and individually in suspension in high concentration without mutual aggregation of the nano-particles. A determined amount of pure water or deionized water is poured into a reactor, into which is introduced nitrogen gas at rate of 300 cm3/min for a given time while agitating with a stirrer to remove dissolved oxygen in the pure water, allowing to stand in an atmosphere of nitrogen. Next, the inside of the reactor is maintained in an atmosphere of nitrogen and sodium citrate as a dispersion-stabilizing agent, an aqueous solution of MPS as a surface-modifying agent, an anion aqueous solution for co-precipitation as a nano-crystal and a cation aqueous solution are added, in that order. Then, an aqueous solution of... |
| High resolution methods and precipitating reagents for isolating proteins from proteinaceous material | 20060223988 | 20061005 |
| Novel high resolution methods and precipitating reagents for isolating desired protein populations from proteinaceous materials are disclosed. Uniquely, the methods and precipitating reagents of this invention are suitable for selectively and sequentially isolating consistently in high yields desired protein populations from various proteinaceous materials based upon the physical and chemical characteristics inherent in, and/or peculiar to, the desired protein populations. In addition, desired protein populations isolated with the new and vastly improved methods and precipitating reagents of this invention are highly concentrated and substantially pure and biologically active. The precipitating reagents basically are an alkali metal salt of a polyfunctional organic acid, exemplified by tri-potassium citrate monohydrate or tri-sodium citrate dihydrate, and a buffer for adjusting pH. Sources of proteinaceous materials may include, for example, animal... |
| Oral care cleaning compositions and methods | 20060204453 | 20060914 |
| An oral cleaning composition including an orally-acceptable cleaning solvent, an orally-acceptable surfactant and an orally-acceptable alkaline agent. Some implementations include one or both of charged and neutral surfactants. In many instances, the cleaning solvent is ethanol, the surfactant is sodium laurel sulfate and the alkaline agent is potassium hydroxide. An additional surfactant of polaxamer and/or an additional alkaline agent of sodium citrate may be included. Either or both of a peroxygen compound and a chelating agent may also be used.
... |
| Oral hygiene device with liquid dentifrice | 20060133885 | 20060622 |
| An Oral Hygiene Device that is a combination toothbrush and a liquid dentifrice that can be either sprayed or rolled onto the teeth for brushing. A case includes a center section, a brush mount, a dentifrice mount and a pair of caps. The brush mount and the dentifrice mount and a pair of caps. The brush mount and the dentifrice mount extend in opposite directions from the center section. A dentifrice dispenser for dispensing a liquid dentifrice is mounted within the dentifrice mount and a toothbrush is mounted within the brush mount. The liquid dentifrice includes by weight a majority of water and glycerine. Silica providing a gentle abrasive while carbonide peroxide serves as a whitener. Sodium citrate reduces acidity and fluoride prevents tooth decay. In... |
| Tonic to maintain intestinal flora | 20060105962 | 20060518 |
| An orally-administered pre-biotic composition for promoting the growth of normal, healthy intestinal flora while preventing the proliferation of unhealthy and toxic intestinal flora. When ingested, the composition improves the natural biological protection of the human body against toxic substances that are present in foods ingested and those that are produced by abnormal intestinal flora. The suspension is comprised of a source of fructose, esters of short chain fatty acids, salts of short chain fatty acids, sodium or potassium chloride, monocalcium phosphate, and sodium citrate.
... |
